Due to COVID-19 we are now offering TeleHealth Office Visits via video or phone call. Learn More >
We have prepared for the Coronavirus (COVID-19). We have updated policies to protect our patients and staff. Learn more.

Archives: July 2020

  • Radiation Therapy for Non- Small Lung Cancer

    July 13, 2020
    A general scope about the treatment of non-small lung cancer. Decatur, Texas, July 13, 2020 – Radiation therapy, also called radiotherapy, involves the use of high-energy rays to kill cancer cells by damaging their DNA and inhibiting their growth and multiplication ability.  Non-small lung cancer is a malignant disease whose cells form in the lung tissues. Healthy cells are affected...read more
  • How Carcinogens Cause the Development of Breast Cancer

    Scientists have created a map with details on how environmental chemicals can trigger breast cancer. They used the ionizing radiation model to identify the cell mechanisms that cause breast cancer when disrupted. Since these findings can be generalized to various environmental carcinogens, they could help find out the chemicals responsible for the high breast cancer risk. Although exposure to toxic...read more
  • Exercise Can Help Protect Against COVID-19 and Prostate Cancer

    Coronavirus became a pandemic quickly, causing many deaths due to a shortage of medical resources such as ventilators for patients and personal protective equipment for care providers in hospitals around the world. COVID-19 can be lethal to people with known vulnerabilities and severe complications. If you have a condition known as Acute Respiratory Distress Syndrome (ARDS), you’re at risk of...read more
  • When Metastatic Lung Cancer Patients Should Stop Using Immunotherapy

    Metastatic lung cancer patients should continue with immunotherapy for up to 2 years if they are responsive and are not experiencing excessive toxicity or disease progression. Initially, stage III lung cancer patients usually undergo immunotherapy for one year as established in one clinical trial. The trial results showed that durvalumab (imfinzi) could prolong overall survival and progression-free survival in stage...read more

More Choice Cancer Care Centers